At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
DVAX Dynavax
Halted 02-26 17:25:34 EST
15.50
+0.00
0.00%
High15.50Low15.50Vol0.00
Open15.50D1 Closing15.50Amplitude0.00%
Mkt Cap1.77BTradable Cap1.77BTotal Shares114.00M
T/O0.00T/O Rate0.00%Tradable Shares114.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

European Stocks Mostly Lower in Tuesday Trading; UK Regulator Seeks Views on Apple, Google Competition Commitments
MT Newswires Live  ·  02-11
European Stocks Mostly Lower in Tuesday Trading; UK Regulator Seeks Views on Apple, Google Competition Commitments
Dynavax Completes Merger and Prepares Nasdaq Delisting
TIPRANKS  ·  02-10
Dynavax Completes Merger and Prepares Nasdaq Delisting
Sanofi Completes Acquisition of Dynavax Technologies
Reuters  ·  02-10
Sanofi Completes Acquisition of Dynavax Technologies
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Reuters  ·  02-10
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
BUZZ-OneSpaWorld jumps as co poised to join S&P SmallCap index
Reuters  ·  02-05
BUZZ-OneSpaWorld jumps as co poised to join S&P SmallCap index
OneSpaWorld to replace Dynavax in S&P 600 at open on 2/10
TIPRANKS  ·  02-05
OneSpaWorld to replace Dynavax in S&P 600 at open on 2/10
Sanofi Buyout Of Dynavax Recasts Adult Vaccine Growth For Shareholders
Simply Wall St.  ·  02-01
Sanofi Buyout Of Dynavax Recasts Adult Vaccine Growth For Shareholders
Sanofi vaccine sales face headwinds from US policy shifts
Reuters  ·  01-29
Sanofi vaccine sales face headwinds from US policy shifts
Is Dynavax Technologies (DVAX) Pricing Reflect Its Recent Rally And DCF Implied Upside Potential
Simply Wall St.  ·  01-14
Is Dynavax Technologies (DVAX) Pricing Reflect Its Recent Rally And DCF Implied Upside Potential
Dynavax Received, Rejected Buyout Offer From Undisclosed Bidder - Update
Dow Jones  ·  01-13
Dynavax Received, Rejected Buyout Offer From Undisclosed Bidder - Update
Evaluating Dynavax (DVAX) After Its Recent Share Price Rally: Is the Stock Still Undervalued?
Simply Wall St.  ·  01-05
Evaluating Dynavax (DVAX) After Its Recent Share Price Rally: Is the Stock Still Undervalued?
Dynavax Technologies Corp: IF Deal Is Terminated Under Some Circumstances, Sanofi to Pay Co Reverse Termination Fee of $116.8 Mln
THOMSON REUTERS  ·  2025-12-29
Dynavax Technologies Corp: IF Deal Is Terminated Under Some Circumstances, Sanofi to Pay Co Reverse Termination Fee of $116.8 Mln
Sanofi to Acquire Dynavax for $15.50 Per Share in Cash
Reuters  ·  2025-12-29
Sanofi to Acquire Dynavax for $15.50 Per Share in Cash
What Caused Biohaven (BHVN) Shares To Drop More Than 16% After Hours?
Benzinga_recent_news  ·  2025-12-25
What Caused Biohaven (BHVN) Shares To Drop More Than 16% After Hours?
Dynavax Technologies (DVAX) Shares Are Trending Overnight — Here's Why
Benzinga_recent_news  ·  2025-12-25
Dynavax Technologies (DVAX) Shares Are Trending Overnight — Here's Why
Nike, Omeros Corporation, Micron Technology, Intel And Dynavax Technologies: Why These 5 Stocks Are On Investors' Radars Today
Benzinga_recent_news  ·  2025-12-25
Nike, Omeros Corporation, Micron Technology, Intel And Dynavax Technologies: Why These 5 Stocks Are On Investors' Radars Today
U.S. Small Caps Rise; Dynavax Technologies Leads Increases
Dow Jones  ·  2025-12-25
U.S. Small Caps Rise; Dynavax Technologies Leads Increases
Dynavax Cut to Market Perform From Outperform by William Blair
Dow Jones  ·  2025-12-25
Dynavax Cut to Market Perform From Outperform by William Blair
BUZZ-U.S. STOCKS ON THE MOVE-Snowflake, Hecla Mining, Newmont
Reuters  ·  2025-12-25
BUZZ-U.S. STOCKS ON THE MOVE-Snowflake, Hecla Mining, Newmont
Top Midday Gainers
MT Newswires Live  ·  2025-12-25
Top Midday Gainers

Introduction

Company Name.
Dynavax
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.
Issue price:
--